异基因造血干细胞移植治疗71例儿童白血病的疗效及影响因素 - Suppr

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.

作者信息

Zhang Bing-Lei, Zhou Jian, Lyu Tian-Xi, Gui Rui-Rui, Zu Ying-Ling, Yu Feng-Kuan, Zhao Hui-Fang, Li Zhen, Wang Juan, Zhang Yan-Li, Zhang Wen-Lin, Fu Yue-Wen, Wei Xu-Dong, Fang Bai-Jun, Li Yu-Fu, Zhou Ke-Shu, Song Yong-Ping

机构信息

Department of Hematology, Tumor Hospital Affiliated to Zhengzhou University, Henan Cancer Hospital, Zhengzhou, Henan 450003, China.

出版信息

Chin Med J (Engl). 2019 Apr 5;132(7):860-864. doi: 10.1097/CM9.0000000000000150.

DOI:10.1097/CM9.0000000000000150

PMID:30897600

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6595847/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5125/6595847/0ffd90580b13/cm9-132-860-g002.jpg

相似文献

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.异基因造血干细胞移植治疗71例儿童白血病的疗效及影响因素

Chin Med J (Engl). 2019 Apr 5;132(7):860-864. doi: 10.1097/CM9.0000000000000150.

Idarubicin-intensified BUCY2 conditioning regimen improved survival in high-risk acute myeloid, but not lymphocytic leukemia patients undergoing allogeneic hematopoietic stem cell transplantation: A retrospective comparative study.伊达比星强化的BUCY2预处理方案改善了接受异基因造血干细胞移植的高危急性髓系白血病患者的生存率，但对淋巴细胞白血病患者无效：一项回顾性比较研究。

Leuk Res. 2016 Jul;46:61-8. doi: 10.1016/j.leukres.2016.04.014. Epub 2016 Apr 19.

Outcome Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia Treated with Total Body Irradiation-Free Allogeneic Hematopoietic Stem Cell Transplantation: Comparison of Patients with and Without Central Nervous System Involvement.儿童急性淋巴细胞白血病患者行无全身放疗异基因造血干细胞移植的疗效分析：合并与不合并中枢神经系统累及患者的比较。

Biol Blood Marrow Transplant. 2017 Dec;23(12):2110-2117. doi: 10.1016/j.bbmt.2017.08.036. Epub 2017 Sep 1.

The Cape Town experience with haematopoietic stem cell transplantation: the paediatric programme.开普敦造血干细胞移植经验：儿科项目

S Afr Med J. 2000 Aug;90(8):804-11.

Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.环磷酰胺联合全身照射、口服白消安或静脉注射白消安用于成人急性淋巴细胞白血病异基因造血细胞移植的比较

Biol Blood Marrow Transplant. 2016 Dec;22(12):2194-2200. doi: 10.1016/j.bbmt.2016.09.007. Epub 2016 Sep 13.

Outcome after failure of allogeneic hematopoietic stem cell transplantation in children with acute leukemia: a study by the société Francophone de greffe de moelle et de thérapie cellulaire (SFGM-TC).急性白血病患儿异基因造血干细胞移植失败后的结局：法国骨髓移植与细胞治疗协会（SFGM-TC）的一项研究

Bone Marrow Transplant. 2017 May;52(5):678-682. doi: 10.1038/bmt.2016.360. Epub 2017 Jan 23.

Treatment of infant leukemia with busulfan, cyclophosphamide +/- etoposide and bone marrow transplantation.用白消安、环磷酰胺+/-依托泊苷及骨髓移植治疗婴儿白血病。

Bone Marrow Transplant. 1992 May;9(5):313-8.

High-dose chemotherapy with busulphan and cyclophosphamide and bone-marrow transplantation for drug-sensitive malignancies in adults: a preliminary report.成人药物敏感性恶性肿瘤的白消安和环磷酰胺大剂量化疗及骨髓移植：初步报告。

Med J Aust. 1989 Oct 2;151(7):379-86. doi: 10.5694/j.1326-5377.1989.tb101219.x.

[The curative efficacy of unrelated umbilical cord blood stem cells transplantation in intensified myeloablative conditioned patients with acute lymphoblastic leukemia].非亲缘脐血干细胞移植治疗急性淋巴细胞白血病强化清髓预处理患者的疗效观察

Zhonghua Nei Ke Za Zhi. 2016 Mar;55(3):191-5. doi: 10.3760/cma.j.issn.0578-1426.2016.03.007.

[Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].[采用FLAG序贯白消安/环磷酰胺预处理方案进行异基因造血干细胞移植治疗难治/复发急性髓系白血病的临床结局]

Zhonghua Nei Ke Za Zhi. 2018 Aug 1;57(8):576-581. doi: 10.3760/cma.j.issn.0578-1426.2018.08.008.

本文引用的文献

Efficacy and Feasibility of Allogeneic Hematopoietic Stem-Cell Transplantation in the Treatment of Refractory Acute Myeloid Leukemia.异体造血干细胞移植治疗难治性急性髓系白血病的疗效和可行性。

Clin Lymphoma Myeloma Leuk. 2019 Mar;19(3):177-182. doi: 10.1016/j.clml.2018.11.016. Epub 2018 Dec 6.

Incidence of childhood cancer in Costa Rica, 2000-2014: An international perspective.2000 - 2014年哥斯达黎加儿童癌症发病率：国际视角

Cancer Epidemiol. 2018 Oct;56:21-30. doi: 10.1016/j.canep.2018.07.004. Epub 2018 Jul 18.

Allogeneic hematopoietic stem cell transplantation for children and adolescents with high-risk cytogenetic AML: distinctly poor outcomes of FUS-ERG-positive cases.异基因造血干细胞移植治疗高危细胞遗传学 AML 患儿和青少年：FUS-ERG 阳性病例的结局明显较差。

Bone Marrow Transplant. 2019 Mar;54(3):393-401. doi: 10.1038/s41409-018-0273-7. Epub 2018 Jun 29.

Comparison of survival outcome between donor types or stem cell sources for childhood acute myeloid leukemia after allogenic hematopoietic stem cell transplantation: A multicenter retrospective study of Study Alliance of Yeungnam Pediatric Hematology-oncology.异基因造血干细胞移植后儿童急性髓系白血病供者类型或干细胞来源的生存结局比较：岭南儿科血液肿瘤学研究联盟的多中心回顾性研究

Pediatr Transplant. 2018 Jun 19:e13249. doi: 10.1111/petr.13249.

The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.中国血液学会关于血液系统疾病异基因造血细胞移植适应证、预处理方案及供者选择的共识。

J Hematol Oncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x.

Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.预处理方案对首次完全缓解期接受移植的急性髓系白血病患儿预后的影响。代表欧洲血液与骨髓移植组儿科疾病工作组所做的分析

Biol Blood Marrow Transplant. 2017 Mar;23(3):467-474. doi: 10.1016/j.bbmt.2016.11.022. Epub 2016 Dec 1.

An overview of infectious complications after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后感染性并发症概述。

J Infect Chemother. 2016 Aug;22(8):505-14. doi: 10.1016/j.jiac.2016.05.006. Epub 2016 Jun 22.

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40-60 years.40-60 岁急性髓系白血病患者缓解后治疗方法的比较治疗价值。

Leukemia. 2015 May;29(5):1041-50. doi: 10.1038/leu.2014.332. Epub 2014 Nov 27.

Allogeneic peripheral blood stem cell transplantation using reduced-intensity conditioning in an outpatient setting in ABO-incompatible patients: are survival and graft-versus-host disease different?在门诊环境中使用减强度预处理的异基因外周血造血干细胞移植在 ABO 不相容患者中的应用：生存率和移植物抗宿主病是否不同？

Transfusion. 2014 May;54(5):1269-77. doi: 10.1111/trf.12466. Epub 2013 Oct 28.

The European LeukemiaNet AML Working Party consensus statement on allogeneic HSCT for patients with AML in remission: an integrated-risk adapted approach.欧洲白血病网络 AML 工作组关于缓解期 AML 患者异基因 HSCT 的共识声明：一种综合风险适应方法。

Nat Rev Clin Oncol. 2012 Oct;9(10):579-90. doi: 10.1038/nrclinonc.2012.150. Epub 2012 Sep 4.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Efficacy and influencing factors of allogeneic hematopoietic stem cell transplantation in treatment of 71 children with leukemia.

作者信息

机构信息

出版信息

相似文献

本文引用的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

本文引用的文献